
A comprehensive end-to-end quality-control framework for spatial transcriptomics is poised to revolutionize the field, ensuring biological fidelity and mitigating artifact risks. By implementing advanced AI-driven segmentation, precise normalization protocols, and innovative dissociation techniques, researchers aim to enhance the resolution and reliability of data analysis. This shift not only improves current methodologies but also establishes benchmarks against gold-standard datasets, paving the way for groundbreaking discoveries in health care.

Title not available for this citation.
“AI-driven 3D models, especially NucleAIzer and StarDist, showed improved precision, lower variance (VP/VS ≈ 0.96), and improved gene spot correlation (r > 0.82) across multiple focal planes.”

Title not available for this citation.
“the similar average number of gene spots per cell nuclei in the AI-based analyses as the eye control counting, despite the elevated number of cell nuclei found with AI, validated the AI nuclear segmentation results.”

Title not available for this citation.
“high-resolution ST confirmed these molecular and cellular interactions in their native context, revealing a significant spatial co-localization of MORF4L1-expressing tumor foci with multiple immunosuppressive immune cell types.”

Title not available for this citation.
“In the APP23 mouse model of AD, pathology-vulnerable brain regions exhibited early, region-specific disruption of diurnal transcription prior to substantial amyloid plaque deposition.”

Title not available for this citation.
“Spatial transcriptomics (ST) provides unprecedented insights into gene expression patterns while retaining spatial context, making it a valuable tool for understanding complex tissue architectures, such as those found in cancers.”